Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The regulation of insulin gene expression in pancreatic beta-cells is the result of the coordinate activity of specific combinations of transcription factors assembled on different promoter elements. We investigated the involvement of the aristaless-related homeoprotein
Alx3
in this process. We found that
Alx3
is coexpressed with insulin in pancreatic islets, as well as in the beta-cell line MIN6, and it is also present in
glucagon
- and somatostatin-expressing cells. Chromatin immunoprecipitation assays indicated that
Alx3
present in MIN6 cells and in mouse pancreatic islets occupies the promoter of the mouse insulin genes. EMSAs indicated that
Alx3
present in MIN6 cells binds to the A3/4 regulatory element of the insulin I promoter. We found that
Alx3
transactivates the insulin promoter by acting on the E2A3/4 enhancer in conjunction with the basic helix-loop-helix transcription factors E47/Pan1 and Beta2/NeuroD, and that
Alx3
physically interacts via the homeodomain with E47/Pan1 but not with Beta2/NeuroD.
Alx3
binds to the A3/4 element as a dimer, and the homeodomain is sufficient to recruit E47/Pan1 to the insulin promoter. Deletion studies in transfected HeLa cells indicated that proline-rich regions located at either side of the
Alx3
homeodomain work together with E47/Pan1, and that this requires the integrity of the amino-terminal activation domain to transactivate. Thus, these studies support the notion that
Alx3
participates in the regulation of insulin gene expression in pancreatic beta-cells.
...
PMID:The homeoprotein Alx3 expressed in pancreatic beta-cells regulates insulin gene transcription by interacting with the basic helix-loop-helix protein E47. 1682 92